Home > Qtrly Results > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹161 Cr ₹147 Cr ₹142 Cr ₹146 Cr ₹156 Cr ₹136 Cr ₹112 Cr ₹134 Cr
Expenses ₹133 Cr ₹125 Cr ₹124 Cr ₹117 Cr ₹125 Cr ₹115 Cr ₹96 Cr ₹107 Cr
Operating Income ₹28 Cr ₹23 Cr ₹18 Cr ₹30 Cr ₹31 Cr ₹21 Cr ₹17 Cr ₹27 Cr
Other Income ₹10 Cr ₹10 Cr ₹7 Cr ₹11 Cr ₹9 Cr ₹8 Cr ₹4 Cr ₹6 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Depreciation ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹2 Cr ₹2 Cr
Profit Before Tax ₹35 Cr ₹29 Cr ₹22 Cr ₹38 Cr ₹37 Cr ₹25 Cr ₹17 Cr ₹31 Cr
Profit After Tax ₹26 Cr ₹24 Cr ₹19 Cr ₹28 Cr ₹28 Cr ₹19 Cr ₹13 Cr ₹22 Cr
EPS ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49 ₹6.27 ₹10.79
Industry Peers & Returns1W1M1Y
LINCOLN PHARMACEUTICALS -3.8% 24.7% 31.4%
SUN PHARMACEUTICAL INDUSTRIES 1% 4.6% 47.5%
CIPLA -1.1% -0.3% 20.7%
DR REDDYS LABORATORIES 2.2% 12.1% 21.6%
ZYDUS LIFESCIENCES -2.7% 0.8% 43.8%
DIVIS LABORATORIES 1% -3.2% 59.3%
MANKIND PHARMA 0.8% 12.8% 52.4%
TORRENT PHARMACEUTICALS -1.5% 5.9% 55%
LUPIN 0.9% 7.2% 72.7%

LINCOLN PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

9.46 %

Y-o-Y

3.35 %

Quarters Revenues % Change
Sep2024 ₹161 Cr
9.46
Jun2024 ₹147 Cr
3.36
Mar2024 ₹142 Cr
-2.70
Dec2023 ₹146 Cr
-6.12
Sep2023 ₹156 Cr
15.02
Jun2023 ₹136 Cr
20.59
Mar2023 ₹112 Cr
-15.93
Dec2022 ₹134 Cr -

LINCOLN PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

24.85 %

Y-o-Y

-8.89 %

Quarters Operating Profit % Change
Sep2024 ₹28 Cr
24.85
Jun2024 ₹23 Cr
23.66
Mar2024 ₹18 Cr
-38.02
Dec2023 ₹30 Cr
-4.78
Sep2023 ₹31 Cr
50.34
Jun2023 ₹21 Cr
24.51
Mar2023 ₹17 Cr
-37.80
Dec2022 ₹27 Cr -
Operating Margins
Q-o-Q

14.06 %

Y-o-Y

-11.87 %

Quarters Operating Margin% % Change
Sep2024 17.6%
14.06
Jun2024 15.43%
19.61
Mar2024 12.9%
-36.30
Dec2023 20.25%
1.40
Sep2023 19.97%
30.69
Jun2023 15.28%
3.24
Mar2023 14.8%
-26.00
Dec2022 20% -

LINCOLN PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

11.23 %

Y-o-Y

-4.78 %

Quarters Profit After Tax % Change
Sep2024 ₹26 Cr
11.23
Jun2024 ₹24 Cr
27.29
Mar2024 ₹19 Cr
-33.67
Dec2023 ₹28 Cr
1.39
Sep2023 ₹28 Cr
45.44
Jun2023 ₹19 Cr
51.36
Mar2023 ₹13 Cr
-41.88
Dec2022 ₹22 Cr -
PAT Margins
Q-o-Q

1.62 %

Y-o-Y

-7.90 %

Quarters PAT Margin(%) % Change
Sep2024 16.33 %
1.62
Jun2024 16.07 %
23.14
Mar2024 13.05 %
-31.85
Dec2023 19.15 %
8.01
Sep2023 17.73 %
26.46
Jun2023 14.02 %
25.51
Mar2023 11.17 %
-30.88
Dec2022 16.16 % -

LINCOLN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

11.25 %

Y-o-Y

-4.78 %

Quarters EPS % Change
Sep2024 ₹13.15
11.25
Jun2024 ₹11.82
27.37
Mar2024 ₹9.28
-33.71
Dec2023 ₹14
1.38
Sep2023 ₹13.81
45.52
Jun2023 ₹9.49
51.36
Mar2023 ₹6.27
-41.89
Dec2022 ₹10.79 -

You may also like the below Video Courses